Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News

    Standard Glass Lining Tech has filed its IPO Papers with SEBI to Raise Funds


    Finance Outlook India Team | Friday, 26 July 2024

    Standard Glass Lining Technology Ltd, which manufactures specialist technical equipment for the pharmaceutical and chemical industries, has filed preliminary paperwork with capital markets regulator Sebi to raise funds through an Initial Public Offering (IPO).

    According to the Draft Red Herring Prospectus (DRHP), the Telangana-based company's IPO will include a fresh offering of Rs 250 crore in shares, as well as an Offer For Sale (OFS) of up to 1.84 crore equity shares by promoters and selling shareholders.

    Ofs shares are being sold by S2 Engineering Services, Standard Holdings, Kandula Ramakrishna, Kandula Krishna Veni, Nageswara Rao Kandula, Katragadda Venkata Ramani, and Venkata Siva Prasad Katragadda. The company may consider raising up to Rs 50 crore through a pre-IPO placement. If such a placement is successful, the new issue size will be reduced.

    The additional proceeds of Rs 130 crore will be used to repay debt, Rs 30 crore to invest in a wholly-owned subsidiary, S2 Engineering Industry, and Rs 20 crore to promote inorganic growth through strategic investments or acquisitions. Rs 10 crore will be used to purchase machinery and equipment, with a portion going for general corporate objectives. Standard Glass Lining Technology offers comprehensive solutions to pharmaceutical and chemical companies, including design, engineering, manufacturing, assembly, installation, and commissioning, as well as the formulation of standard operating procedures.

    The company's product portfolio includes key equipment used in the manufacture of pharmaceutical and chemical products. It serves 443 clients from various industries, including pharmaceuticals, chemicals, paint, biotechnology, and food and beverage.

    Some of its pharmaceutical clients include Aurobindo Pharma Ltd, Cadila Pharmaceutical Ltd, Deccan Fine Chemicals (India) Private Limited, Laurus Labs Ltd, Granules India Ltd, Macleods Pharmaceuticals Ltd, Natco Pharma Ltd, Piramal Pharma Ltd, Suven Pharmaceuticals Ltd, and Tagros Chemicals India.

    In terms of finances, Standard Glass Lining Technology's operational revenue increased by 9.26% to Rs 543.67 crore in fiscal 2024, from Rs 497.59 crore in fiscal 2023. Furthermore, profit after tax rose by 12.33% to Rs 60 crore in fiscal 2024, up from Rs 53.42 crore in fiscal 2023. IIFL Securities and Motilal Oswal Investment Advisors are the book-running lead managers for the upcoming public offering. The equity shares are scheduled to be listed on the BSE and NSE.



    Read More:

    Piyush Goyal Announces Rs 10,000 Crore Fund of Funds for Startups

    Ashika Institutional, MOFSL & Bajaj Broking Markets Closing Commentary

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us